Dr. Reddy's Laboratories Limited
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference bb696333dd
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
52 acceptance records as first applicant, grouped into 24 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Enzalutamide Soft Capsules 3 records · Latest accepted 2026/10/15
Supplement · 2Import · 1
Lenalidomide Capsules 4 records · Latest accepted 2026/06/16
Import re-registration · 2Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600145 | Import re-registration | 2026/06/16 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHZ2600144 | Import re-registration | 2026/06/16 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHB2200406 | Supplement | 2022/08/01 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHB2200405 | Supplement | 2022/08/01 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Vigabatrin Powder for Oral Solution 1 records · Latest accepted 2026/06/16
Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600146 | Import re-registration | 2026/06/16 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Abiraterone Acetate Tablets 1 records · Latest accepted 2025/09/01
Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2500197 | Import re-registration | 2025/09/01 | Dr. Reddy's Laboratories Limited; Rui Di Bo Shi (Beijing) Pharma Co., Ltd. romanized | CDE ↗ |
Iron Sucrose Injection 2 records · Latest accepted 2024/08/17
Not stated by source · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2400140 | Not stated by source | 2024/08/17 | Dr. Reddy's Laboratories Limited; Rui Di Bo Shi (Beijing) Pharma Co., Ltd. romanized | CDE ↗ |
| JTH2400101 | Not stated by source | 2024/07/16 | Dr. Reddy's Laboratories Limited; Rui Di Bo Shi (Beijing) Pharma Co., Ltd. romanized | CDE ↗ |
Olanzapine Tablets 4 records · Latest accepted 2024/07/10
Import re-registration · 2Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2400184 | Import re-registration | 2024/07/10 | Dr. Reddy's Laboratories Limited; Name not romanized | CDE ↗ |
| JYHZ2400183 | Import re-registration | 2024/07/10 | Dr. Reddy's Laboratories Limited; Name not romanized | CDE ↗ |
| JYHB2101334 | Supplement | 2021/08/17 | Dr.Reddy's Laboratories Limited | CDE ↗ |
| JYHB2101332 | Supplement | 2021/08/17 | Dr.Reddy's Laboratories Limited | CDE ↗ |
Dabigatran Etexilate Capsules 4 records · Latest accepted 2024/04/19
Import · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHS2400021 | Import | 2024/04/19 | Dr. Reddy's Laboratories Limited; Dr. Reddy's (Beijing) Pharmaceutical Co. Ltd. | CDE ↗ |
| JYHS2400020 | Import | 2024/04/19 | Dr. Reddy's Laboratories Limited; Dr. Reddy's (Beijing) Pharmaceutical Co. Ltd. | CDE ↗ |
| JYHS2100009 | Import | 2021/01/20 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHS2100008 | Import | 2021/01/20 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Clopidogrel Hydrogen Sulphate Tablets 3 records · Latest accepted 2024/04/11
Supplement · 2Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2400153 | Supplement | 2024/04/11 | Dr.Reddy's Laboratories Limited | CDE ↗ |
| JYHZ2300103 | Import re-registration | 2023/02/24 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHB2101280 | Supplement | 2021/07/27 | Dr. Reddy's Laboratories Limited | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/04/04
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2400085 | Import | 2024/04/04 | Dr. Reddy's Laboratories Limited; Dr. Reddy's (Beijing) Pharmaceutical Co. Ltd. | CDE ↗ |
Lansoprazole Orally Disintegrating Tablets 1 records · Latest accepted 2023/11/16
Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2300264 | Not stated by source | 2023/11/16 | Dr. Reddy's Laboratories Limited; Zhong Huan Pharmaceuticals Co., Ltd. romanized | CDE ↗ |
Fulvestrant Injection 2 records · Latest accepted 2023/11/16
Supplement · 1Import · 1
Regadenoson Injection 1 records · Latest accepted 2023/09/14
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHL2300001 | Import | 2023/09/14 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Dimethyl Fumarate Delayed-release Capsules 2 records · Latest accepted 2023/08/16
Import · 2
Erlotinib Hydrochloride Tablets 4 records · Latest accepted 2023/03/29
Import · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHS2300045 | Import | 2023/03/29 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHS2300044 | Import | 2023/03/29 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHS2100050 | Import | 2021/03/26 | Dr.Reddy's Laboratories Limited | CDE ↗ |
| JYHS2100049 | Import | 2021/03/26 | Dr.Reddy's Laboratories Limited | CDE ↗ |
Sacubitril Valsartan Sodium Tablets 2 records · Latest accepted 2023/02/12
Import · 2
Sevelamer Carbonate Powder for oral suspension 2 records · Latest accepted 2022/04/18
Import · 2
Doxorubicin Hydrochloride Liposome Injection 2 records · Latest accepted 2022/01/30
Import · 2
Lurasidone Hydrochloride Tablets 1 records · Latest accepted 2021/11/08
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHS2101055 | Import | 2021/11/08 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Tetrabenazine Tablets 2 records · Latest accepted 2021/09/13
Import · 2
Trientine Hydrochloride Capsules 1 records · Latest accepted 2021/06/18
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHS2101020 | Import | 2021/06/18 | Dr. Reddy's Laboratories Limited; Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited | CDE ↗ |
Sitagliptin Phosphate Tablets 3 records · Latest accepted 2021/05/13
Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHS2101014 | Import | 2021/05/13 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHS2101013 | Import | 2021/05/13 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHS2101012 | Import | 2021/05/13 | Dr.Reddy's Laboratories Limited; Dr. Reddy's Laboratories Limited | CDE ↗ |
Carboprost Tromethamine Injection 1 records · Latest accepted 2021/03/02
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHS2100039 | Import | 2021/03/02 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Atomoxetine Hydrochloride Capsules 4 records · Latest accepted 2021/02/02
Import · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHS2100024 | Import | 2021/02/02 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHS2100023 | Import | 2021/02/02 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHS2100022 | Import | 2021/02/02 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| JYHS2100021 | Import | 2021/02/02 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Vigabatringranules for Oral Solution 1 records · Latest accepted 2021/01/25
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHS2100012 | Import | 2021/01/25 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Changes in the last 90 days
1 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 1 application
- 2026/10/15Accepted
Enzalutamide Soft Capsules
JYHB2600552
Fact date: 2026/10/15 · Site observation date: 2026/10/22
View source ↗
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Enzalutamide Soft Capsules | JYHB2600552 | Supplement | 2026/10/15 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| Vigabatrin Powder for Oral Solution | JYHZ2600146 | Import re-registration | 2026/06/16 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| Lenalidomide Capsules | JYHZ2600145 | Import re-registration | 2026/06/16 | Dr. Reddy's Laboratories Limited | CDE ↗ |
| Lenalidomide Capsules | JYHZ2600144 | Import re-registration | 2026/06/16 | Dr. Reddy's Laboratories Limited | CDE ↗ |
Catalogue holder records
11 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Lansoprazole Orally Disintegrating Tablets | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Limited | 国药准字HJ20250115 | 2025/09/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nilotinib Capsules | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Limited | 国药准字HJ20250067 | 2025/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nilotinib Capsules | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Limited | 国药准字HJ20250068 | 2025/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Enzalutamide Soft Capsules | Dr. Reddy's Laboratories Limited | Dr. Reddy’s Laboratories Limited | 国药准字HJ20240126 | 2024/10/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Erlotinib Hydrochloride Tablets | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Limited | 国药准字HJ20240114 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Erlotinib Hydrochloride Tablets | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Limited | 国药准字HJ20240115 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dasatinib Tablets | Dr. Reddy's Laboratories Limited | Dr. Reddy' s Laboratories Limited | 国药准字HJ20240085 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Doxorubicin Hydrochloride Liposome Injection | Dr. Reddy's Laboratories Limited | Natco Pharma Limited | 国药准字HJ20240055 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Doxorubicin Hydrochloride Liposome Injection | Dr. Reddy's Laboratories Limited | Natco Pharma Limited | 国药准字HJ20240056 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lurasidone Hydrochloride Tablets | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Limited | 国药准字HJ20230104 | 2023/09/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Abiraterone Acetate Tablets | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Limited | 国药准字HJ20210014 | 2021/03/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
17 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | Dr. Reddy's Laboratories Limited | Y20230000479 | A | 2026/05/20 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20210000873 | A | 2026/05/20 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20210000637 | A | 2024/10/30 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20210000099 | A | 2024/12/29 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20200001323 | A | 2024/09/20 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20200001084 | A | 2026/08/11 | CDE ↗ |
| No verified English name | Dr.Reddy's Laboratories Limited | Y20200000250 | A | 2024/09/06 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20190009993 | A | 2024/11/07 | CDE ↗ |
| No verified English name | Dr. Reddy＇s Laboratories Limited | Y20190009188 | A | 2025/01/21 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20180001291 | I | 2019/03/26 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20170001952 | A | 2026/03/06 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20170001640 | A | 2026/10/23 | CDE ↗ |
| No verified English name | Dr.Reddy's Laboratories Limited | Y20170001609 | A | 2025/02/27 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20170001566 | A | 2024/07/10 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20170001510 | A | 2026/08/07 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20170001482 | A | 2025/07/24 | CDE ↗ |
| No verified English name | Dr. Reddy's Laboratories Limited | Y20170000050 | A | 2025/01/19 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
1 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Levothyroxine Sodium Tablets | JTH2200197 | Not stated by source | 2022/09/25 | Steril-Gene Life Sciences (P) Ltd.; Dr. Reddy's Laboratories Limited; Rui Di Bo Shi (Beijing) Pharma Co., Ltd. romanized | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.